Whole genome expression profiling reveals a significant role for the cell junction and apoptosis pathways in breast cancer stem cells

Molecular Biotechnology

Volumn 45, Issue 1, 2010, Pages 39-48

  Huang, Mingzhu ^a   Li, Yuqing ^b   Wu, Guohua ^a   Zhang, Fengchun ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Breast neoplasm; Cancer stem cells; Gene regulatory networks; Microarray; Side population cells

Indexed keywords

APOPTOSIS; BREAST CANCER; BREAST NEOPLASM; CELL LINES; CELL POPULATIONS; DIFFERENTIALLY EXPRESSED GENE; EXPRESSION PROFILING; GENE EXPRESSION ANALYSIS; GENE EXPRESSION PROFILES; GENE REGULATORY NETWORKS; HUMAN BREAST CANCER CELLS; IN-VITRO; IN-VIVO; MCF-7 CELLS; MULTIPLE PATHWAYS; TUMORIGENICITY;

CELL CULTURE; CELL DEATH; CELL MEMBRANES; CELL PROLIFERATION; CRYOGENIC LIQUIDS; GENE EXPRESSION; TUMORS;

STEM CELLS;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER STEM CELL; CARCINOGENICITY; CELL ISOLATION; CELL JUNCTION; CELL SELECTION; CELL STRAIN MCF 7; CELL SUBPOPULATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE REGULATORY NETWORK; GENOME; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA PURIFICATION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME MAPPING; GENE EXPRESSION PROFILING; GENOME; INTERCELLULAR JUNCTIONS; MICE; MICE, SCID; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954819552     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12033-010-9241-1     Document Type: Article

References (32)

1. Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001). Estimating the world cancer burden: Globocan 2000. International Journal of Cancer, 94, 153-156.
2. Zhang, M., & Rosen, J. M. (2006). Stem cells in the etiology and treatment of cancer. Current Opinion in Genetics and Development, 16, 60-64.
3. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 100, 3983-3988. (Pubitemid 36418143)
4. Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3, 730-737.
5. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research, 65, 10946-10951.
6. Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432, 396-401.
7. Kim, C. F., Jackson, E. L., Woolfenden, A. E., Lawrence, S., Babar, I., Vogel, S., et al. (2005). Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell, 121, 823-835.
8. O'Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445, 106-110.
9. Houghton, J., Stoicov, C., Nomura, S., Rogers, A. B., Carlson, J., Li, H., et al. (2004). Gastric cancer originating from bone marrow-derived cells. Science, 306, 1568-1571.
10. Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J. M., et al. (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research, 68, 4311-4320.
11. Goodell, M. A., Brose, K., Paradis, G., Conner, A. S., & Mulligan, R. C. (1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. Journal of Experimental Medicine, 183, 1797-1806.
12. Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., et al. (2004). A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proceedings of the National Academy of Sciences of the United States of America, 101, 14228-14233.
13. Patrawala, L., Calhoun, T., Schneider-Broussard, R., Zhou, J., Claypool, K., & Tang, D. G. (2005). Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2-cancer cells are similarly tumorigenic. Cancer Research, 65, 6207-6219.
14. Kondo, T., Setoguchi, T., & Taga, T. (2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proceedings of the National Academy of Sciences of the United States of America, 101, 781-786.
15. Quackenbush, J. (2006). Microarray analysis and tumor classification. New England Journal of Medicine, 354, 2463-2472.
16. Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., et al. (2007). let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell, 131, 1109-1123.
17. Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., et al. (2007). The prognostic role of a gene signature from tumorigenic breast-cancer cells. New England Journal of Medicine, 356, 217-226.
18. Liu, S., Dontu, G., Mantle, I. D., Patel, S., Ahn, N. S., Jackson, K. W., et al. (2006). Hedgehog signaling and Bmi-1 regulate selfrenewal of normal and malignant human mammary stem cells. Cancer Research, 66, 6063-6071.
19. Zhou, J., Wulfkuhle, J., Zhang, H., Gu, P., Yang, Y., Deng, J., et al. (2007). Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proceedings of the National Academy of Sciences of the United States of America, 104, 16158-16163.
20. Clarke, M. F., & Fuller, M. (2006). Stem cells and cancer: Two faces of eve. Cell, 124, 1111-1115.
21. Nagafuchi, A. (2001). Molecular architecture of adherens junctions. Current Opinion in Cell Biology, 13, 600-603.
22. Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciarkova, M., Ehrmann, J., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer, 7, 55.
23. Spradling, A., Drummond-Barbosa, D., & Kai, T. (2001). Stem cells find their niche. Nature, 414, 98-104.
24. Song, X., & Xie, T. (2002). DE-cadherin-mediated cell adhesion is essential for maintaining somatic stem cells in the Drosophila ovary. Proceedings of the National Academy of Sciences of the United States of America, 99, 14813-14818.
25. Kabashima, A., Higuchi, H., Takaishi, H., Matsuzaki, Y., Suzuki, S., Izumiya, M., et al. (2009). Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. International Journal of Cancer, 124, 2771-2779.
26. Tsukita, S., & Furuse, M. (2000). The structure and function of claudins, cell adhesion molecules at tight junctions. Annals of the New York Academy of Sciences, 915, 129-135.
27. Schmelzer, E., Zhang, L., Bruce, A., Wauthier, E., Ludlow, J., Yao, H. L., et al. (2007). Human hepatic stem cells from fetal and postnatal donors. Journal of Experimental Medicine, 204, 1973-1987.
28. Blumenthal, R. D., Leon, E., Hansen, H. J., & Goldenberg, D. M. (2007). Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers. BMC Cancer, 7, 2.
29. Laack, E., Nikbakht, H., Peters, A., Kugler, C., Jasiewicz, Y., Edler, L., et al. (2002). Expression of CEACAM1 in adenocarcinoma of the lung: A factor of independent prognostic significance. Journal of Clinical Oncology, 20, 4279-4284.
30. Thom, I., Schult-Kronefeld, O., Burkholder, I., Schuch, G., Andritzky, B., Kastendieck, H., et al. (2009). Expression of CEACAM-1 in pulmonary adenocarcinomas and their metastases. Anticancer Research, 29, 249-254.
31. Madjd, Z., Mehrjerdi, A. Z., Sharifi, A. M., Molanaei, S., Shahzadi, S. Z., & Asadi-Lari, M. (2009). CD44+ cancer cells express higher levels of the anti-apoptotic protein Bcl-2 in breast tumours. Cancer Immunity, 9, 4.
32. Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., et al. (2006). Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype. Clinical Cancer Research, 12, 5615-5621.